| Title | Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment; The relationship will bolster Antidote's DE&I initiatives in patient recruitment and support NMHA's health equity mission t |
| Publication Type | Newspaper Article |
| Year of Publication | 2022 |
| Authors | McElroy Agrace anti |
| Keywords | Biotechnology, clinical trials, Consumer, Contract/Agreement, Corporate Social Responsibility, Diversity in clinical trials, General Health, Health, Managed Care, Men, New York, North America, Other Consumer, Other Health, Other Philanthropy, Other Science, Philanthropy, Research, Science, United States, Women |
| Abstract | Antidote Technologies (Antidote), a patient centric digital engagement company focused on connecting patients with clinical research, today announced a collaboration with the National Minority Health Association (NMHA), a leading national health equity advocacy organization dedicated to closing the disparity gap in minority health care. The relationship will help ensure that all patients have access to the latest treatment options, including promising new drugs currently being tested in clinical trials... |
Topics:
